raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:913

Zollinger-Ellison syndrome

Synonyms: Gastrinoma

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult, Elderly
Status
active

A rare neuroendocrine neoplasm (NEN) characterized by severe peptic disease (ulcers/esophageal disease) caused by hypergastrinemia secondary to a gastrin-secreting NEN (gastrinoma) resulting in increased gastric acid secretion.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enZollinger-Ellison syndromeGastrinoma
frSyndrome de Zollinger-EllisonGastrinome
deZollinger-Ellison-SyndromGastrinom
esSíndrome de Zollinger-Ellison= en
itSindrome di Zollinger-Ellison= en
nlSyndroom van Zollinger-EllisonGastrinoom
ptSíndrome Zollinger-Ellison= en
plZespół Zollingera i Ellisona= en
csZollingerův-Ellisonův syndromGastrinom · Zollinger-Ellisonův syndrom
ukСиндром Золлінгера-ЕллісонаГастринома
zhZollinger-Ellison 综合征胃泌素瘤
trZollinger-Ellison sendromu= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10E16.4NTBTinclusionvalidated
ICD-115A43.1Especificvalidated
MONDO0019610Evalidated
MeSHD015043Evalidated
UMLSC0043515Evalidated
GARD7918Evalidated
MedDRA10017852Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

6 records
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.15 / 100 000EuropeValue and classValidated[EXPERT]
Point prevalence1-9 / 100 000—EuropeClass onlyValidated[EXPERT]
Annual incidence1-9 / 1 000 0000.15 / 100 000DenmarkValue and classValidatedISBN:0849359937[OTHER]
Annual incidence1-9 / 1 000 0000.3 / 100 000SwitzerlandValue and classNot yet validatedISBN:0849359937[OTHER]
Annual incidence<1 / 1 000 0000.05 / 100 000IrelandValue and classValidated2575263[PMID]
Annual incidence1-9 / 1 000 0000.125 / 100 000WorldwideValue and classValidated22261919[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

34 annotations · validated 2017-01-25
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0100634Neuroendocrine neoplasm
HP:0002044Zollinger-Ellison syndrome
Very frequent (99-80%)
HP:0002014Diarrhea
HP:0002588Duodenal ulcer
HP:0002574Episodic abdominal pain
HP:0100633Esophagitis
HP:0002018Nausea
HP:0004398Peptic ulcer
Frequent (79-30%)
HP:0001824Weight loss
Occasional (29-5%)
HP:0008256Adrenocortical adenoma
HP:0000845Elevated circulating growth hormone concentration
HP:0003165Elevated circulating parathyroid hormone level
HP:0010783Erythema
HP:0012334Extrahepatic cholestasis
HP:0002239Gastrointestinal hemorrhage
HP:0030404Glucagonoma
HP:0002573Hematochezia
HP:0003072Hypercalcemia
HP:0000843Hyperparathyroidism
HP:0003118Increased circulating cortisol level
HP:0030688Increased glucagon level
HP:0012030Increased urinary cortisol level
HP:0005214Intestinal obstruction
HP:0000952Jaundice
HP:0012032Lipoma
HP:0001012Multiple lipomas
HP:0008208Parathyroid hyperplasia
HP:0002893Pituitary adenoma
HP:0008291Pituitary corticotropic cell adenoma
HP:0011760Pituitary growth hormone cell adenoma
HP:0011761Pituitary null cell adenoma
HP:0006767Pituitary prolactin cell adenoma
HP:0000854Thyroid adenoma
Very rare (<4-1%)
HP:0006744Adrenocortical carcinoma

Run the differential on the 8 obligate / very frequent terms

Annotation source: 23582916[PMID]_22052063[PMID]_23645327[PMID]_21443889[PMID]_21315717[PMID]_19854317[PMID]_19836486[PMID]_18270260[PMID]_19059523[PMID]

7

Sources for this card